Bulgaria
· Delayed Price · Currency is BGN Sopharma AD Statistics
Total Valuation
Sopharma AD has a market cap or net worth of BGN 991.06 million. The enterprise value is 1.34 billion.
| Market Cap | 991.06M |
| Enterprise Value | 1.34B |
Important Dates
The next estimated earnings date is Thursday, January 30, 2025.
| Earnings Date | Jan 30, 2025 |
| Ex-Dividend Date | Jul 11, 2024 |
Share Statistics
Sopharma AD has 165.73 million shares outstanding. The number of shares has increased by 26.74% in one year.
| Shares Outstanding | 165.73M |
| Shares Change (YoY) | +26.74% |
| Shares Change (QoQ) | +54.61% |
| Owned by Insiders (%) | 9.17% |
| Owned by Institutions (%) | 4.91% |
| Float | 40.65M |
Valuation Ratios
The trailing PE ratio is 12.30.
| PE Ratio | 12.30 |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| PB Ratio | 1.23 |
| P/FCF Ratio | 38.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.41, with an EV/FCF ratio of 51.68.
| EV / Earnings | 17.33 |
| EV / Sales | 0.68 |
| EV / EBITDA | 9.41 |
| EV / EBIT | 13.56 |
| EV / FCF | 51.68 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 44.15.
| Current Ratio | 1.46 |
| Quick Ratio | 0.70 |
| Debt / Equity | 44.15 |
| Debt / EBITDA | 2.98 |
| Debt / FCF | 13.92 |
| Interest Coverage | 6.11 |
Financial Efficiency
Return on equity (ROE) is 10.70% and return on invested capital (ROIC) is 4.40%.
| Return on Equity (ROE) | 10.70% |
| Return on Assets (ROA) | 3.44% |
| Return on Capital (ROIC) | 4.40% |
| Revenue Per Employee | 403,192 |
| Profits Per Employee | 15,849 |
| Employee Count | 4,721 |
| Asset Turnover | 1.39 |
| Inventory Turnover | 4.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.24% |
| 50-Day Moving Average | 5.93 |
| 200-Day Moving Average | 6.02 |
| Relative Strength Index (RSI) | 51.80 |
| Average Volume (20 Days) | 13,765 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sopharma AD had revenue of BGN 1.97 billion and earned 77.60 million in profits. Earnings per share was 0.49.
| Revenue | 1.97B |
| Gross Profit | 429.34M |
| Operating Income | 77.86M |
| Pretax Income | 91.42M |
| Net Income | 77.60M |
| EBITDA | 103.62M |
| EBIT | 77.86M |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 26.36 million in cash and 362.21 million in debt, giving a net cash position of -335.86 million or -2.03 per share.
| Cash & Cash Equivalents | 26.36M |
| Total Debt | 362.21M |
| Net Cash | -335.86M |
| Net Cash Per Share | -2.03 |
| Equity (Book Value) | 820.40M |
| Book Value Per Share | 4.84 |
| Working Capital | 241.22M |
Cash Flow
In the last 12 months, operating cash flow was 47.87 million and capital expenditures -21.85 million, giving a free cash flow of 26.02 million.
| Operating Cash Flow | 47.87M |
| Capital Expenditures | -21.85M |
| Free Cash Flow | 26.02M |
| FCF Per Share | 0.16 |
Margins
Gross margin is 21.75%, with operating and profit margins of 3.94% and 3.93%.
| Gross Margin | 21.75% |
| Operating Margin | 3.94% |
| Pretax Margin | 4.63% |
| Profit Margin | 3.93% |
| EBITDA Margin | 5.25% |
| EBIT Margin | 3.94% |
| FCF Margin | 1.32% |
Dividends & Yields
This stock pays an annual dividend of 0.99, which amounts to a dividend yield of 16.56%.
| Dividend Per Share | 0.99 |
| Dividend Yield | 16.56% |
| Dividend Growth (YoY) | 65.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 273.99% |
| Buyback Yield | -26.74% |
| Shareholder Yield | -10.19% |
| Earnings Yield | 8.13% |
| FCF Yield | 2.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sopharma AD has an Altman Z-Score of 3.16.
| Altman Z-Score | 3.16 |
| Piotroski F-Score | n/a |